AR and prostate carcinoma: Previous reports have indeed outlined that crosstalk between androgen receptor (AR), NF-κB, and Wnt/β-catenin signaling is imperative in increasing the metastasis and progression of prostate cancers (Lee et al., 2013; Koushyar et al., 2022).